Abstract:BACKGROUND: Partial breast radiotherapy (PBI) has emerged as an option after breast-conserving surgery for early stage breast cancer patients.METHODS: A total of 55 patients with early stage breast cancer between 2009 and 2013 were enrolled in this single-institutional phase II prospective clinical trial. All patients received adjuvant PBI-IMRT after lumpectomy, with the prescription of 48 Gy in 12 fractions at 4 Gy per fraction, 5 days a week. The primary endpoint was ipsilateral breast tumor recurrence (IBTR), the other endpoints were a regional nodal failure (RNF), distant metastasis (DM) rate, disease-free survival (DFS), and overall survival (OS). These endpoints were used to evaluate clinical outcomes. The cosmetic effects and the late toxicity were assessed according to Harvard standard scale and CTCAE 3.0, respectively.RESULTS: In our cohorts, the median age was 45.60 years old (range 31-65 years) and 29.09% of these patients were post-menopause (<i>n</i> = 16). Most patients were T1 stage (65.45%) or N0 stage (70.91%). 80% of patients were ER-positive, 67.27% PR positive, and 61.82% HER2 negative. At the median follow-up of 9.25 years, RNF was 0% and IBTR occurred in only one patient (1.82%) to the chest wall. Except for one patient (1.82%) had DM to lung and pleura and died from disease progression, the remaining patients were alive at the end of the 10-year follow-up. The 10-year DFS and OS were 94.55 and 98.18%. One patient (1.82%) was diagnosed with endometrial cancer after PBI. Except for 9 patients who declined the cosmetic assessment, the rest of the 46 patients (83.64%) were all rated as good and well-satisfied with the appearance of the irradiated breast. No breast retraction and fibrosis were observed in any of the patients. Additionally, only 4 patients experienced grade 1 late toxicity (7.28%). None had grade 3 or higher late toxicity.CONCLUSION: This is the first study to report the 10-year results of PBI after breast-conserving surgery in Chinese patients. Our study suggested that PBI had durable local control and maintained good cosmetic outcomes with minimal late toxicity at long term follow up for the early stage breast cancer patients.

Adjuvant Breast Inversely Planned Intensity-Modulated Radiotherapy with Simultaneous Integrated Boost for Early Stage Breast Cancer

Immobilization-assisted Abdominal Deep Inspiration Breath-Hold in Post-Mastectomy Radiotherapy of Left-Sided Breast Cancer with Internal Mammary Chain Coverage

Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients

Adjuvant Breast Radiotherapy Using a Simultaneous Integrated Boost for Early-Stage Breast Cancer: Results from a Phase II Trial

A prospective study of intensity-modulated radiotherapy with integrated boost after breast conservative surgery in breast cancer patients

Comparison of clinical efficacy between simultaneous integrated boostintensity-modulated radiotherapy (SIB-IMRT) and late-course boost intensity-modulated radiotherapy (LB-IMRT) for early-stage breast cancer after breast-conserving surgery

Dosimetric character and curative effect of postoperative radiotherapy with tumor bed boost simultaneously using IMRT in early breast cancer patients

Intensity modulated radiotherapy for patients with early-stage breast cancer after breast-conserving surgery pins 122 cases analysis

Clinical Results of Phase 2 Study of Whole-Breast Irradiation with Simultaneously Integrated Tumor Bed Boost (WBI-SIB): A Single-Center Experience

Simultaneous Integrated Boost Intensity-Modulated Radiotherapy For Locally Advanced Non-Small Cell Lung Cancer In Chinese Population: A Retrospective Study

Long-Term Results of Partial Breast Irradiation After Breast-Conserving Surgery for Early Stage Breast Cancer: A Prospective Phase II Trial in China

A Randomized Controlled Study of Sequential Boost Radiotherapy and Simultaneous Integrated Boost Radiotherapy in Early Patients After Breast Conserving Surgery

Analysis of Dosimetry and Clinical Outcome Using Intensity Modulated Radiation Therapy for Early Breast Cancer Patients after Breast Conservative Surgery

Multibeam Inverse Intensity-Modulated Radiotherapy (IMRT) for Whole Breast Irradiation: a Single Center Experience in China.

Intensity-modulated radiation therapy with simultaneous integrated boost for locally advanced breast cancer: a prospective study on toxicity and quality of life

The clinic research of intensity modulated radiation therapy after breast-conserving surgery of breast cancer

Dosimetric Comparison of the Simultaneous Integrated Boost in Whole-Breast Irradiation after Breast-Conserving Surgery: Imrt, Imrt Plus an Electron Boost and Vmat

Efficacy and Toxicity of IMRT-Based Simultaneous Integrated Boost for the Definitive Management of Positive Lymph Nodes in Patients with Cervical Cancer.

Results of a Clinical Phase II Trial of Whole Breast Irradiation with a Hypofractionated Simultaneous Integrated Boost to the Tumor Bed after Breast-Conserving Surgery for Early Breast Cancer

Intensity-modulated radiotherapy for breast cancer: a systematic review

Accelerated Hypofractionated Whole-Breast Irradiation with Concomitant Daily Boost Using Intensity-Modulated Radiation Therapy in Early Breast Cancer